Peptide Therapeutics Market, By Product Type (Branded Peptide and Generic Peptide), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others), By Route of Administration (Oral Administration, Parenteral Administration, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Feb 2023

Code : CMI1837

Pages :184

Formats :

Excel and PDF

Industry : Pharmaceutical

Market News

Global Peptide Therapeutics Market: Key Developments

On August 5, 2021, Bayer AG, a Life Science company, announced the acquisition of Vividion Therapeutics, Inc., a U.S.-based biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics.

In December 2021, Sanofi, a global healthcare company, announced that it has entered into an agreement to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company, giving away its clinically validated product XTEN and innovative protease-releasable masking technology platform, Pro-XTENTM, to discover and develop transformative T-cell engagers (TCE) and cytokine therapies for patients with cancer.

In September 2022, the life science group Sartorius, through its subgroup Sartorius Stedim Biotech, successfully closed the acquisition of Albumedix Ltd, a world leading manufacturer of recombinant human albumin. This acquisition will enable Sartorius to strengthen their position as a relevant supplier of innovative chemically defined media and critical ancillary materials

In November 2022, Mesa Laboratories, Inc., a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced the acquisition of substantially all of the assets and certain liabilities related to Belyntic GmbH’s peptide purification business. Belyntic GmbH is a chemistry-for-healthcare enterprise focusing on purification of biopolymers, particularly peptides.